MSI2 and colorectal carcinoma: Three days after MSI2 depletion, use of a WST-1/CelltiterBlue assay indicated that MSI2 depletion significantly decreased viability of both the RKO and HCT116 human CRC cell lines versus cells bearing negative control shRNA (Fig 4E and 4F).